CPH Cipher Pharmaceuticals Inc.

9.150USD13.09 CAD · TSX+0.31%Mkt Cap: 232.56M USDP/E: 7.15

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and r…

Insiders, last 90 days5 buys
Institutional holders11 on file

Key Statistics

Company
Market Cap232.56M USD
Enterprise Value221.60M USD
Revenue (TTM)49.49M USD
Gross Profit40.42M USD
Net Income (TTM)27.33M USD
Revenue/Share1.95 USD
Last Price9.150 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA17253X1050
Valuation
P/E (Trailing)7.15
P/E (Forward)11.48
PEG—
EV/EBITDA10.16
EV/Revenue4.48
P/S6.72
P/B1.61
EPS (TTM)1.83 USD
EPS (Forward)1.14 USD
52W Range
8.9204% of range14.37
52W High14.37 USD
52W Low8.920 USD
Profitability
Gross Margin80.12%
Oper. Margin49.06%
EBITDA Margin63.02%
Profit Margin54.17%
ROE21.65%
ROA17.46%
ROIC13.57%
ROCE12.83%
Growth
Revenue Growth-1.00%
Earnings Growth100.00%
Cash Flow & Leverage
Operating CF29.73M USD
CapEx (TTM)201.00K USD
FCF Margin30.28%
FCF Yield6.44%
Net Debt-14.68M USD
Net Debt/EBITDA-0.47
Net Debt/FCF-0.98
Balance Sheet
Debt/Equity0.04
Current Ratio1.99
Quick Ratio1.56
Book Value/Sh8.11 USD
Cash/Share0.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.84 USD
Upside (mean)+40.4%
Target Range9.787 USD – 14.33 USD
9.787+40.4% to mean14.33
# Analysts4
Ownership
Shares Out.25.42M
Float14.78M
Insiders42.74%
Institutions1.32%
Short Interest
Short Ratio0.5d
Short % Out.0.04%
Shares Short9.74K
Short (prev mo.)31.04K
Technical
SMA 509.589 (-4.6%)
SMA 20011.00 (-16.8%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)23.30K
Avg Vol (10d)31.86K
Technical Indicators
RSI (14)42.6
MACD-0.0905
MACD Signal-0.0831
MACD Hist.-0.0075
BB Upper9.773 USD
BB Middle9.358 USD
BB Lower8.944 USD
BB Width8.86%
ATR (14)0.3082 USD
Vol Ratio (20d)1.14x

About Cipher Pharmaceuticals (TSE: CPH)

›

Cipher Pharmaceuticals (TSE: CPH) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 13.09 CAD on 19 November 2026, down 2.9% over 52 weeks. Its 52-week range is 12.76 CAD to 20.56 CAD: the price is 36.3% below the high and 2.6% above the low.

At a market capitalisation of 332.68M CAD, it trades at 7.2 times trailing earnings and 11.5 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 71% for CPH.

Cipher Pharmaceuticals reports return on equity of 21.6%, an operating margin of 49.1% and revenue down 1.0% year over year.

It holds more cash than debt, a net cash position of 14.68M USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 18.38 CAD is 40.4% above the current price.